Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

IM Cannabis Corp (IMCC)

IM Cannabis Corp (IMCC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,535
  • Shares Outstanding, K 69,690
  • Annual Sales, $ 43,330 K
  • Annual Income, $ -14,170 K
  • 60-Month Beta N/A
  • Price/Sales 0.89
  • Price/Cash Flow N/A
  • Price/Book 0.29
Trade IMCC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.61
  • Most Recent Earnings -0.13 on 05/12/22
  • Next Earnings Date 08/15/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 506.73% ( -209.43%)
  • Historical Volatility 100.75%
  • IV Percentile 93%
  • IV Rank 45.14%
  • IV High 1,069.52% on 05/23/22
  • IV Low 43.65% on 09/10/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 106
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 630
  • Open Int (30-Day) 609

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +84.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3940 +65.84%
on 08/03/22
0.7300 -10.49%
on 07/14/22
-0.0465 (-6.64%)
since 07/12/22
3-Month
0.3940 +65.84%
on 08/03/22
1.1800 -44.63%
on 05/13/22
-0.3367 (-34.01%)
since 05/12/22
52-Week
0.3940 +65.84%
on 08/03/22
4.9588 -86.82%
on 08/13/21
-4.3266 (-86.88%)
since 08/12/21

Most Recent Stories

More News
Senestech, Inc. (SNES) Reports Q2 Loss, Lags Revenue Estimates

Senestech, Inc. (SNES) delivered earnings and revenue surprises of -10.53% and 24.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SNES : 0.6000 (-12.82%)
IMCC : 0.6534 (+18.76%)
Xinteza Unveils Disruptive Non-Cannabaceae Source for Cannabinoid Biosynthesis in Breakthrough Research Led by Prof. Asaph Aharoni at the Weizmann Institute of Science

/PRNewswire/ -- Xinteza API Ltd., an innovative biosynthesis technology company, announced today that it has expanded its IP portfolio with a breakthrough...

IMCC : 0.6534 (+18.76%)
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of 30.93% and 78.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MGNX : 5.22 (+2.55%)
IMCC : 0.6534 (+18.76%)
Strength Seen in Abbott (ABT): Can Its 3.1% Jump Turn into More Strength?

Abbott (ABT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near...

ABT : 111.48 (+0.90%)
IMCC : 0.6534 (+18.76%)
IM Cannabis Corp. (IMCC) Reports Q1 Loss, Lags Revenue Estimates

IM Cannabis Corp. (IMCC) delivered earnings and revenue surprises of -550% and 6.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

IMCC : 0.6534 (+18.76%)
RMTI : 1.8400 (+6.36%)
National Vision (EYE) Q1 Earnings Top Estimates

National Vision (EYE) delivered earnings and revenue surprises of 22.22% and 4.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

EYE : 35.65 (+5.91%)
IMCC : 0.6534 (+18.76%)
Meridian Bioscience (VIVO) Q2 Earnings and Revenues Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 37.50% and 11.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

VIVO : 32.71 (+0.49%)
IMCC : 0.6534 (+18.76%)
Vapotherm (VAPO) Reports Q1 Loss, Tops Revenue Estimates

Vapotherm (VAPO) delivered earnings and revenue surprises of -38.10% and 1.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

VAPO : 1.8000 (unch)
IMCC : 0.6534 (+18.76%)
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of -22.22% and 4.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ATRC : 51.98 (+2.46%)
IMCC : 0.6534 (+18.76%)
ResMed (RMD) Q3 Earnings and Revenues Lag Estimates

ResMed (RMD) delivered earnings and revenue surprises of -8.33% and 4.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RMD : 239.99 (-0.36%)
IMCC : 0.6534 (+18.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.

See More

Key Turning Points

3rd Resistance Point 0.9361
2nd Resistance Point 0.8231
1st Resistance Point 0.7382
Last Price 0.6534
1st Support Level 0.5403
2nd Support Level 0.4273
3rd Support Level 0.3424

See More

52-Week High 4.9588
Fibonacci 61.8% 3.2150
Fibonacci 50% 2.6764
Fibonacci 38.2% 2.1378
Last Price 0.6534
52-Week Low 0.3940

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar